» Authors » Kan Ni

Kan Ni

Explore the profile of Kan Ni including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 83
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang Y, Ni K, Jin K, Feng W, Ju S, Jing R, et al.
Naunyn Schmiedebergs Arch Pharmacol . 2025 Feb; PMID: 39992418
One of the most common gastrointestinal tumors is gastric cancer (GC), which has a high lethality and a poor prognosis. Recently, it was discovered that mature tRNAs, which are expressed...
2.
Cao Y, Ni K, Kawaguchi T, Hashimoto S
Sensors (Basel) . 2024 Jan; 24(2). PMID: 38257654
Autonomous mobile robots have become integral to daily life, providing crucial services across diverse domains. This paper focuses on path following, a fundamental technology and critical element in achieving autonomous...
3.
Ren T, Wu J, Qian L, Liu J, Ni K
Comput Math Methods Med . 2022 Sep; 2022:4491573. PMID: 36158135
Objective: To compare the efficacy and psychology of breast-conserving surgery and modified radical mastectomy in patients with early breast cancer (BC) under graded nursing. Methods: Forty-one early breast-conserving surgery BC...
4.
Ke J, Ni K, Xue H, Li J
Oncol Lett . 2021 Dec; 23(1):27. PMID: 34868364
Breast cancer (BC) is a common type of malignant tumor that is frequently accompanied by drug resistance, which is a significant challenge in the treatment of BC. Adriamycin (ADM) is...
5.
Wang G, Ni K, Gu C, Huang J, Chen J, Wang X, et al.
Oncol Rep . 2021 Jul; 46(2). PMID: 34278497
Erythropoietin‑producing hepatocellular receptors (Ephs) comprise the largest subfamily of receptor tyrosine kinases and have been reported to be involved in a variety of biological cellular processes, including tumorigenesis and cancer...
6.
Ni K, Huang Z, Zhu Y, Xue D, Jin Q, Zhang C, et al.
Front Oncol . 2021 Jun; 11:654472. PMID: 34178640
Background: Long non-coding RNAs (lncRNAs) are key regulators of triple-negative breast cancer (TNBC) progression, but further work is needed to fully understand the functional relevance of these non-coding RNAs in...
7.
Huang Z, Li X, Xie T, Gu C, Ni K, Yin Q, et al.
Cancer Res Treat . 2020 Jul; 52(4):1067-1083. PMID: 32599985
Purpose: RIOK1 has been proved to play an important role in cancer cell proliferation and migration in various types of cancers-such as colorectal and gastric cancers. However, the expression of...
8.
Jin Q, Liu G, Wang B, Li S, Ni K, Wang C, et al.
J Clin Pathol . 2020 May; 73(12):803-812. PMID: 32404475
Aims: Methionyl-tRNA synthetase (MARS) is known to play a critical role in initiating translation and protection against cellular damages in vivo. The aim of this study was to clarify the...
9.
Ma P, Ni K, Ke J, Zhang W, Feng Y, Mao Q
Exp Biol Med (Maywood) . 2018 Jan; 243(5):473-480. PMID: 29368542
Recently, accumulating evidence provides that dysregulation of microRNAs (miRNAs) is considered to play vital roles in tumor progression. Based on microRNA arrays, we found that microRNA-448 (miR-448) was significantly downregulated...
10.
Zhang X, Wang W, Li P, Wang X, Ni K
Hum Pathol . 2017 Nov; 72:91-99. PMID: 29104108
Triggering receptor expressed on myeloid cells 2 (TREM2) is a member of the immunoglobulin superfamily and associates with TYRO protein tyrosine kinase-binding protein at the cell membrane to form a...